Use of Name. Except as expressly provided in this Agreement, neither Party shall mention or otherwise use the name, logo, trademark, service mark, registered design, or physical likeness of the other Party or any of its Affiliates (or any abbreviation or adaptation thereof) or any of such Party’s or its Affiliates respective officers, directors or employees in any publication, press release, marketing and promotional material, or other form of publicity without the prior written approval of such other Party in each instance, which approval may be withheld at such Party’s sole discretion. The restrictions imposed by this [Section 12.1.5] shall not prohibit either Party from making any disclosure identifying the other Party that, in the opinion of the Disclosing Party’s counsel, is required by Law (including any securities law or regulation or the rules of a securities exchange or as a requirement in filing for an International Nonproprietary Name (INN) or the like) or with a legal or administrative proceeding, or in connection with prosecuting or defending litigation; provided that such Party shall submit the proposed disclosure identifying the other Party in writing to the other Party as far in advance as reasonably practicable so as to provide a reasonable opportunity to comment thereon.

Use of Name. Except as provided below, Licensee shall not, and shall ensure that its Affiliates and Sublicensees shall not, use or register the name “Harvard” (alone or as part of another name) or any logos, seals, insignia or other words, names, symbols or devices that identify Harvard or any Harvard school, unit, division or affiliate (“Harvard Names”) for any purpose except with the prior written approval of, and in accordance with restrictions required by, Harvard. Without limiting the foregoing, Licensee shall, and shall ensure that its Affiliates and Sublicensees shall, cease all use of Harvard Names on the termination or expiration of this Agreement except as otherwise approved by Harvard. This restriction shall not apply to any information required by law to be disclosed to any governmental entity.

USE OF NAME. Unless expressly provided otherwise herein, nothing in this Agreement gives either party the right to use the name of the other party in any manner without prior written consent of said other party. However, Licensee shall have the right, at its sole discretion, to mention and disclose RCT as its licensor for the RCT EXPRESSION TECHNOLOGY. However, each of RCT and Licensee must keep the terms of this Agreement strictly confidential and may not disclose the terms of this Agreement to any third party without the other party’s prior written consent, which the other party may withhold in its sole discretion. Each party may disclose the content and terms of this Agreement to its legal counsel and its outside accountants without obtaining the other party’s prior written consent. Each party represents and warrants that before the execution and delivery of this Agreement, it has disclosed none of the substance of the negotiations leading to this Agreement nor the contemplated financial terms of this Agreement to any third party except its legal counsel and outside accountants.

Use of Name. From and after the Closing Date, each Contributor covenants and agrees not to use the name “EnTrust,” “Permal” or “​” or any other name (or brand or other business or source identifier) that consists of, contains, or is confusingly similar to “EnTrust,” “Permal” or “​”, other than in connection with the ownership and operation of the Company and its Subsidiaries or as permitted under [Section 6.7] or [Section 12.8], or to describe # the name of either Contributor or any other Party, # the prior name of the EnTrust Contributed Entities or the Permal Contributed Entities, as applicable, # the prior ownership of the EnTrust Contributed Entities or the Permal Contributed Entities, as applicable and # the Permal Funds, PMAP Funds or the EnTrust Funds, in each case only to the extent permitted by Applicable Law.

Use of Name. Neither party may use the other party’s name nor that of Institution in any form of advertising, promotion or publicity, including press releases, without the prior written consent of the other party. This section does not restrict a party’s ability to use the other party’s

Use of Name. Except as authorized in this Agreement or otherwise required by applicable law, regulation or the rules of any securities exchange or other trading market on which such Party's securities are listed, neither Party shall use the name of the other Party in any publicity or advertising without the prior written approval of the other Party, except that either Party may disclose that it has entered into this Agreement.

Use of UNIVERSITY’s Name. The use of the name of UNIVERSITY, or any contraction thereof, in any manner in connection with the exercise of rights under this LICENSE AGREEMENT is expressly prohibited without the prior written consent of UNIVERSITY, provided that, notwithstanding the foregoing, LICENSEE shall have the right to identify UNIVERSITY as the licensor and, under conditions of confidentiality, to disclose the terms of this LICENSE AGREEMENT to prospective investors, acquirors, sublicensees, strategic partners, investment bankers, and regulatory authorities, in connection with its financing, regulatory, licensing, development, and stockholder relations activities or that it may deem to be required in any prospectus, offering memorandum, or other document or filing prepared in connection with its compliance obligations under applicable securities law or other applicable law or regulation.

Use of Director’s Name. To facilitate successful marketing, financing and development of the Company, Director agrees to allow the Company to use Director’s name and biographical information in connection with its marketing, financial and strategic ventures.

Name Change. Immediately following the Closing, [[Organization A:Organization]] shall file amendments to [[Organization A:Organization]]’s Articles of Organization with the Michigan Secretary of State and any other corporate registry recording its qualification or license to do business changing its corporate name to a name or names that Purchaser reasonably determines is not likely to cause confusion with [[Organization A:Organization]]’s current name or any other name included in the Assets. [[Organization A:Organization]] further agree that, following the Closing, neither [[Organization A:Organization]] nor any of its Affiliates will adopt any name which Purchaser reasonably determines is likely to cause confusion with [[Organization A:Organization]]’s current name for any business and will not otherwise infringe upon the names, or holding themselves out as the successors to the Business.

Name Change. References to “Repro Med Systems, Inc. d/b/a ​” throughout the Employment Agreement and Option Agreement are hereby deleted and replaced with “​”